Tiny OncoSec Surges on Promising Phase II Melanoma Data Post author:Sam Post published:November 7, 2017 Post category:BioPharma The updated data will be presented at the 2017 Society for Immunotherapy of Cancer Annual Meeting. Source: BioSpace You Might Also Like Poor Mid-Stage Results Sink AbbVie’s Plans for Cancer Drug March 21, 2018 Arrogance and Greed: Ackman, Valeant Pay $290M to End Allergan Insider Trading Lawsuit January 1, 2018 Ethicon Release: Company Announces Acquisition Of MEGADYNE January 19, 2017
Arrogance and Greed: Ackman, Valeant Pay $290M to End Allergan Insider Trading Lawsuit January 1, 2018